Navigation Links


MMX in Medical News

Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13

...ent, Commercial Operations, Santarus, Inc. mmx (R) Technology - The Benefits of Targeted Deliv...rohn's and Colitis Organization Budesonide mmx (R) - Clinical Development Program in Ulcerative ...g Center for Travelers' Health Rifamycin SV mmx (R) - Clinical Development Program in Traveler'...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

...y ulcerative colitis treatment that utilizes MMX(R) Technology. Lialda with mmx Technology combines a pH dependent gastro-resistant coating, which delays t...ialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. For further information please contact: Investor Relatio...

Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis

...y ulcerative colitis treatment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays t...ialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. Important Safety Information for LIALDA LIALDA tablets are ...

Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives

...tment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistan...y. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. Important Safety Information for LIA...ani and Shire Pharmaceuticals. Cosmo's proprietary mmx technology is at the core of the company's product...

LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon

...on, with a tablet core containing mesalamine with hydrophilic and lipophilic excipients. LIALDA is the only ulcerative colitis treatment that utilizes mmx Technology. In two pivotal phase III clinical studies, LIALDA was shown to be superior to placebo in inducing remission and treating the symptoms ...
MMX in Medical Technology

Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

-- Primary endpoint achieved -- LAINATE, Italy - July 4, 2007 - Cosmo Pharmaceuticals SpA (SWX:COPN) announced today positive preliminary results from its phase II/III study with CB-01-11 (Rifamycin SV MMX(tm)) in infectious diarrhoea. CB-01-11 is a broad spectrum, semi-synthetic antibiotic that...

Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW

...y ulcerative colitis treatment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays t...ialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. SHIRE PLC Shire's strategic goal is to become the leading s...

New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG

...tment that utilizes MMX(R) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistan...y. Cosmo Pharmaceuticals SpA, Milan, developed the mmx Technology. For more information about LIALDA and...ani and Shire Pharmaceuticals. Cosmo's proprietary mmx Technology is at the core of the company's product...

Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life

...new formulation in this class to be approved since 2000. LIALDA is the only ulcerative colitis treatment that utilizes MMX(TM) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ...

Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW

...new formulation in this class to be approved since 2000. LIALDA is the only ulcerative colitis treatment that utilizes MMX(TM) Technology. LIALDA with mmx Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ...
MMX in Biological Technology

Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis

...ally the patient population who may benefit most." Once-daily LIALDA with mmx technology contains the highest mesalamine dose per tablet (1.2 g), so pati...ialisation rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the mmx technology. For more information about LIALDA and for Full Prescribing In...
Other TagsCitrateCholinesterase
(Date:12/2/2009)..., EUROECHO 2009 is the official congress of the E...egistered branch of the European Society of Cardio...imaging will be presented. , New case reports w... latest evidence highlighting the role of this new... in imaging techniques, it is likely that non-inva...
(Date:12/2/2009)..., AB First Aid has been a... foundation in 1980. With quality products, profes... for first aid supplies, AB First Aid has establis...ce, air ambulance care, and as a first aid supplie...amily business is about to enter into its next pha...
(Date:12/2/2009)..., On Sunday, more than 90...e country will cross the finish line at the Rock &...d by Zappos.com, raising over $3.2 million for the... marathon training program, Team Challenge (www.cc...e, the funds will go toward research, education, a...
(Date:12/2/2009)..., , ATLANTA, Dec. 2 In r... the U.S. military, FamilyLife, a non-profit minis..., will present its Weekend to Remember® mar...tary couples in Atlanta from Dec. 11 - 13 at the G...d NE). Weekend to Remember is a marriage getawa...
(Date:12/2/2009)..., , Ad in Today,s Washington Post ...ewswire-USNewswire/ -- If the Catholic bishops ...tative measures we take for granted may be under t...ght to bear on the debate over healthcare reform h...Washington Post warns of the likely impact if tha...
Breaking Medicine News(10 mins):Health News:Media alert: EUROECHO 2009 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2
(Date:12/2/2009)... the University of Salamanca and another from Yale...ors affects the behaviour of Acanthodactylus beer... in the Near East. According to the study, these r...ent prey if they are under pressure from predators...esult, but until now there had been very few exper...
(Date:12/1/2009)... Yerkes National Primate Research Center, Emory Un...ansgenic prairie voles, an important step toward u... future application of this technology will enable...ions that will help identify the brain mechanisms ...rs. This advancement may also have important impli...
(Date:12/1/2009)...vailable in German . , Brown adipose tissue i... of mitochondria, miniature power stations which ...they normally generate a voltage similar to that o...ar processes. However, the mitochondria of brown f...ahead all the time. The energy released when the f...
Breaking Biology News(10 mins):Lizards change their diet to avoid predators 2Yerkes researchers create first transgenic prairie voles 2Brown fat cells make 'spare tires' shrink 2Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 1Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 2Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 3World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 1World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 2World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 3World renowned nanotechnology expert proves there is big potential in the smallest of matter 49908 4Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 1Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 2Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 3Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 4
Other Contentsparoxysmparotidparrotparrotparrotpartialpartialpartialpartialpartialpartialpartialpartialpartialpartialpatchespatchespatchespatchespatchespatellapatella